Balaji Amines

1,207.15
-36.00
(-2.90%)
Market Cap
3,911.29 Cr
EPS
63.22
PE Ratio
21.70
Dividend Yield
0.89 %
Industry
Chemicals
52 Week High
2,549.75
52 Week Low
1,171.00
PB Ratio
2.27
Debt to Equity
0.02
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+100.00 %
+100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %

Company News

View All News
Caret
neutral
Anti-Dumping Investigation Initiated on Ethylene Diamine Imports4 days ago
An anti-dumping investigation has been initiated concerning imports of Ethylene Diamine originating from or exported by China PR, European Union, Kingdom of Saudi Arabia, and Taiwan. This investigation may impact Balaji Amines, a potential domestic producer of the chemical.
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,849.30
#1 1,44,928.95
72.68
12,522.60
#1 5.69
#1 1,747
9.04
59.88
2,939.15
87,123.70
76.00
13,221.50
-11.53
1,336
6.99
54.72
4,022.85
44,191.01
96.50
4,387.70
-25.09
435
57.50
64.96
1,983.60
27,054.92
39.29
7,757.90
-3.26
811
-51.46
44.07
424.35
20,949.36
41.15
4,227.40
0.66
411
29.69
46.24
4,210.85
20,874.67
79.21
2,120.90
0.37
271
7.18
59.68
4,423.70
19,148.27
#1 32.04
#1 13,843.30
-
563
-26.05
44.15
6,136.60
18,067.23
40.95
4,783.90
-13.69
324
#1 62.41
62.65
1,580.95
16,389.02
42.39
1,938.80
-8.77
323
21.85
46.38
390.75
14,165.47
39.26
6,380.70
-3.61
417
-62.90
43.54
Growth Rate
Revenue Growth
-29.50 %
Net Income Growth
-42.74 %
Cash Flow Change
-36.66 %
ROE
-48.64 %
ROCE
-51.69 %
EBITDA Margin (Avg.)
-19.70 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
261
218
240
227
224
229
228
260
224
283
393
418
453
529
566
785
675
630
589
477
469
387
392
423
393
356
321
Expenses
201
172
196
179
186
183
185
202
170
209
275
285
309
394
406
584
455
455
458
378
366
327
309
316
319
286
267
EBITDA
60
46
44
48
39
46
43
57
55
74
118
133
144
134
160
201
220
175
130
99
104
61
83
107
74
70
54
Operating Profit %
23 %
21 %
18 %
21 %
17 %
20 %
19 %
22 %
24 %
26 %
30 %
31 %
31 %
25 %
28 %
25 %
32 %
27 %
22 %
20 %
21 %
14 %
19 %
24 %
17 %
17 %
15 %
Depreciation
5
5
5
5
6
8
8
10
8
9
9
9
10
11
11
11
11
11
12
11
12
11
11
12
12
12
12
Interest
3
3
4
3
3
7
6
6
4
5
5
4
3
4
5
7
3
2
3
3
2
2
2
1
1
1
1
Profit Before Tax
52
38
36
40
30
31
29
41
42
60
104
120
132
119
145
183
205
162
115
85
90
48
70
93
62
57
41
Tax
18
7
9
13
12
3
9
11
11
16
25
32
34
31
43
52
57
43
31
30
23
12
15
20
16
15
10
Net Profit
34
31
26
26
19
29
21
30
32
44
79
89
97
88
102
131
148
119
84
55
68
36
56
73
46
42
31
EPS in ₹
10.44
9.56
8.11
8.16
5.91
9.70
7.22
9.51
10.17
14.12
23.14
26.08
27.90
24.61
27.64
33.56
37.95
28.57
19.31
14.63
16.28
10.71
15.24
21.00
13.36
12.65
10.24

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
623
605
635
848
1,046
1,113
1,310
1,745
1,963
2,146
Fixed Assets
341
341
326
316
320
573
543
681
781
896
Current Assets
276
245
280
355
449
461
577
907
1,032
997
Capital Work in Progress
3
16
25
123
270
46
173
141
113
205
Investments
0
0
0
0
0
48
0
0
73
0
Other Assets
278
248
284
409
457
446
594
923
996
1,046
Total Liabilities
623
605
635
848
1,046
1,113
1,310
1,745
1,963
2,146
Current Liabilities
256
216
199
257
308
264
243
301
149
149
Non Current Liabilities
136
109
74
106
146
180
158
130
115
104
Total Equity
230
280
363
485
592
668
910
1,315
1,698
1,893
Reserve & Surplus
221
274
356
461
568
652
888
1,243
1,548
1,715
Share Capital
7
7
7
7
7
7
7
7
7
7

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-3
2
-5
21
-4
-12
11
16
63
-15
Investing Activities
-4
-29
-10
-135
-119
-130
-62
-147
-210
-164
Operating Activities
56
85
61
140
94
144
110
220
354
224
Financing Activities
-55
-54
-55
16
21
-26
-38
-57
-81
-75

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
53.70 %
53.68 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
53.70 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.52 %
4.57 %
4.92 %
5.05 %
5.27 %
5.16 %
DIIs
0.13 %
0.02 %
0.02 %
0.03 %
0.03 %
0.04 %
0.06 %
0.38 %
0.34 %
0.18 %
0.90 %
1.43 %
1.48 %
1.59 %
1.79 %
1.66 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
39.35 %
39.46 %
37.87 %
38.39 %
37.97 %
37.44 %
35.92 %
36.03 %
36.10 %
36.28 %
35.62 %
35.17 %
34.82 %
34.53 %
34.07 %
34.21 %
Others
6.83 %
6.83 %
8.41 %
7.89 %
8.30 %
8.82 %
10.32 %
9.89 %
9.86 %
9.84 %
5.26 %
5.13 %
5.08 %
5.13 %
5.16 %
5.26 %
No of Share Holders
33,127
55,742
73,341
1,07,412
1,21,044
1,19,651
1,20,785
1,29,702
1,36,644
1,40,957
1,44,990
1,41,417
1,38,017
1,32,428
1,29,160
1,29,361

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2.2 2.6 2.8 3.2 4 6 10 11 0.00
Dividend Yield (%) 0.00 0.39 0.52 1.11 0.18 0.14 0.31 0.49 0.91 0.00

Corporate Action

Announcements

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot5 days ago
Closure of Trading Window8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation10 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 22, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 21, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 21, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Integrated Filing (Financial)Feb 12, 2025
Financial Results For The Quarter And Nine Months Ended 31.12.2024Feb 12, 2025
Board Meeting Outcome for Outcome Of The Board MeetingFeb 12, 2025
Board Meeting Intimation for Board Meeting Intimation For Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended 31Feb 05, 2025
Disclosure Under Regulation 30 Read With Clause 20 Of Para A Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 27, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Closure of Trading WindowDec 31, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 10, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 09, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 09, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 23, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 19, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 14, 2024
Appointment of Company Secretary and Compliance OfficerNov 14, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerNov 14, 2024
Results-Financial Results For The Quarter And Half Year Ended 30Th September, 2024Nov 14, 2024
Board Meeting Outcome for Outcome Of Board MeetingNov 14, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2024
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Nov 10, 2024
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2024Nov 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 04, 2024
Closure of Trading WindowSep 30, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 24, 2024
Clarification On Price MovementSep 19, 2024
Clarification sought from Balaji Amines LtdSep 19, 2024
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011Sep 06, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 05, 2024
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015Aug 14, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 09, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationAug 08, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 07, 2024
Board Meeting Outcome for Outcome Of Board MeetingAug 07, 2024
Results - Financial Results For 30Th June, 2024Aug 07, 2024
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended 30Th June, 2024.Jul 26, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportJul 13, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 11, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 04, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 01, 2024

Technical Indicators

RSI(14)
Neutral
36.16
ATR(14)
Volatile
61.54
STOCH(9,6)
Neutral
44.17
STOCH RSI(14)
Neutral
57.42
MACD(12,26)
Bullish
12.66
ADX(14)
Strong Trend
31.44
UO(9)
Bearish
37.36
ROC(12)
Downtrend And Accelerating
-5.08
WillR(14)
Oversold
-84.03

About Balaji Amines

Balaji Amines Ltd. (BAL) is an Indian company incorporated in 1988, specializing in the manufacture of specialty chemicals, aliphatic amines, and derivatives. The company operates four manufacturing facilities across Maharashtra and Telangana, and owns a five-star hotel in Solapur. BAL's product portfolio includes amines, derivatives, specialty chemicals, and pharma excipients. The company has three main business segments: Specialty Chemicals and Amines, Hotel, and CFL Lamps. BAL supplies to various blue-chip companies and has expanded its operations over the years, including the establishment of new plants, diversification into derivatives production, and the development of renewable energy sources. The company has received several certifications and awards for its products and export performance.
Chairperson NameA Prathap Reddy